Docuniv is a purpose-built reading platform for doctors treating diabetes and metabolic disorders only — bringing together peer-reviewed articles, rich case studies, conference highlights, evidence-based guidelines, clinical algorithms, and a live AI tutor, all in one mobile-first space designed for the pace of real clinical life.
A doctor explains in 30 seconds what DocUniv is and why doctors should be on it. Tap play, with sound on.
Article
Early Identification and Management of Type 2 Diabetes in Primary Care
Type 2 diabetes is silent for years. Opportunistic screening, prompt confirmation and early intensive management in primary care reduce long-term c...
✓ Content reviewer: Baishali
Article
Semaglutide in Type 2 Diabetes: Lessons from the SUSTAIN and PIONEER Programmes
SUSTAIN (injectable) and PIONEER (oral) programmes established semaglutide as a potent glucose- and weight-lowering agent with cardiovascular safet...
✓ Content reviewer: Baishali
Article
Semaglutide versus Tirzepatide for Obesity and Type 2 Diabetes: Interpreting SURMOUNT-5
SURMOUNT-5, the first randomised head-to-head trial in obesity, showed greater weight loss with tirzepatide than semaglutide over 72 weeks. Earlier...
✓ Content reviewer: Baishali
Article
Kidney Protection with GLP-1 Receptor Agonists: FLOW Trial Evidence in Type 2 Diabetes with CKD
FLOW showed that once-weekly semaglutide 1.0 mg reduced major kidney events by 24% in people with type 2 diabetes and chronic kidney disease (CKD),...
✓ Content reviewer: Suja
Article
GLP-1 Receptor Agonist Safety: Retinopathy, Psychiatric Signals and Perioperative Guidance
GLP-1 receptor agonists are generally well tolerated, but concerns regarding diabetic retinopathy, optic neuropathy, psychiatric effects and aspira...
✓ Content reviewer: Suja
Case Study
Identifying MASLD and Assessing Fibrosis Risk in a Patient with Type 2 Diabetes
Metabolic dysfunction-associated steatotic liver disease (MASLD) is frequently encountered in individuals with type 2 diabetes mellitus (T2DM) and ...
✓ Content reviewer: SujaCurrent topics and evidence summaries.
Clinical reasoning through real cases.
Short meeting updates for quick reading.
Treatment pathways and quick reference flows.
Module-linked guideline topics.
Medical headlines, read and approved before they appear.
Type a question about medicines, diet, symptoms, cases, algorithms, guidelines, or conference updates.
Your AI tutor is ready without an account. Type a question — drug interactions, differential diagnoses, dosing, guidelines — and continue into full guided learning modules when you're ready to go deeper.
Type a question about medicines, diet, symptoms, cases, algorithms, guidelines, or conference updates.